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Abstract 
Background: This study reported a comprehensive approach (comparing the extraction yields, chemical profiles, 
antioxidant properties and CYP450‑inhibitory effects) to evaluated the effectiveness of various extraction methods 
[microwave‑assisted extraction using water (MAE‑W), heat reflux extraction using water (HRE‑W), ultrasonic extraction 
using 70 % ethanol and ultrasonic extraction using ethanol (UE‑E)] for Huang‑Qin (HQ), the dried root of Scutellaria 
baicalensis Georgi.
Results: The HQ extraction efficiency by MAE‑W was the best. The chemical profiles of extracts obtained using 
HRE‑W and MAE‑W were similar; whereas more flavones but less flavone glycosides were detected in the UE‑E extract. 
There was no difference in the antioxidant properties among different extracts. In vitro human liver microsome assays 
illustrated that all extracts possessed herb–drug interaction potentials but the UE‑E extract are shown with a potent 
interaction with CYP3A4‑metabolized drugs.
Conclusion: MAE‑W is a favorable method for the preparation of HQ extracts based on extraction yield, pharmaco‑
logical properties and safety.
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Background
There are different widely available and affordable 
extraction methods such as heat reflux extraction 
(HRE), microwave-assisted extraction (MAE) and ultra-
sonic extraction (UE) for routine herbal extraction. 
Comparisons always focus on the yields of crude extracts 
of the same herb using different extraction methods, 
but more importantly comparing the pharmacological/
toxicological effects of extracts obtained are lacking. In 
this study, Huang-Qin (HQ), the root of Scutellaria bai-
calensis Georgi, was chosen as the model to evaluate the 
effectiveness of different extraction methods because its 
chemical properties and major components have been 
well studied and information is available in the literature 
for comparison. A successful search for a cost-efficient 
(i.e. a better yield of active component with similar/
improved therapeutic activities using the same amount of 
herb) extraction method for this herb can lay down the 
foundation for future use of this method for other more 
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expensive herbs with favourable outcomes both finan-
cially and therapeutically.
HQ is a widely used medicinal plant for treatment of 
various diseases (Chien et al. 2010; Shang et al. 2010); it 
is also used as food supplement for health-care purposes 
because of its antioxidant properties (Chan et  al. 2008). 
HQ is rich in flavones and flavone glycosides (baicalein, 
wogonin and their glycosides), while baicalin and wogon-
oside are generally believed to be its major active ingre-
dients. Flavones and flavone glycosides found in HQ are 
responsible for its reported anti-cancer, anti-inflamma-
tory (Li-Weber 2009), vasorelaxant (Huang et  al. 2005), 
anti-viral and other biological activities (Chan et al. 2011; 
Cui et al. 2010; Liu et al. 2011; Zhang et al. 2015). Cur-
rently, there are more than 87 formulations and con-
coctions containing HQ extract indexed in the Chinese 
Pharmacopoeia (Comission 2010). As mentioned in the 
Chinese Pharmacopeia, HQ is routinely prepared using 
heat reflux extraction using water (HRE-W) procedures 
and baicalin is used as reference for quality control pur-
pose. In addition, heat reflux extraction using ethanol 
(HRE-E), ultrasonic extraction (UE) with organic solvents 
(and water) and microwave-assisted extraction (MAE) 
(Horvath et  al. 2005; You et  al. 2010) are alternative 
extraction methods that in general provide better yields 
of HQ crude extract. However, simply looking at the yield 
of extract obtained is bias because extraction methods 
making use of ethanol/organic solvent in general result in 
better yields of extract, but with more hydrophobic prod-
ucts. Moreover, as observed in a Danshen (Salvia Miltio-
rrhiza) study, extracts prepared by different extraction 
methods have varied pharmacological effects (Zhou et al. 
2012a). Unfortunately, extraction using organic solvent is 
not a common household practice, and more importantly 
unwanted or even toxic substances could accumulate in 
the extract at levels which are high enough to pose seri-
ous health hazards, but may exist only in minimal levels 
when water is used.
The aim of this study was to quantify and compare the 
yields of HQ extracts given by different extraction meth-
ods, namely conventional heat reflux extraction using 
water (HRE-W), microwave-assisted extraction using 
water (MAE-W) and ultrasonic extraction using etha-
nol (70 % vol/vol) (UE-E) or water (UE-W) as solvent. In 
addition, the chemical profiles of different HQ extracts 
were characterized, their anti-oxidant potentials were 
estimated, and the magnitudes of CYP450s-mediated 
herb–drug interactions were evaluated.
Methods
Reagents and materials
HQ herb was purchased from a TCM distributor (Man-
San-Tong, Macao, China) and ground into fine powder 
for extraction. The voucher sample (Lot. No. 11-803) 
of HQ herb was authenticated by a botanist, Ms. Huan 
Zhang, and kept in Prof. Yiu Wa Kwan’s laboratory, 
School of Biomedical Sciences, Faculty of Medicine, The 
Chinese University of Hong Kong, Hong Kong. Authentic 
standards (purity > 95 %) of baicalin and baicalein were 
purchased from Nanjing Zelang Co. (Nanjing, China); 
those of wogonoside and wogonin were from Hong 
Kong Jockey Club Institute of Chinese Medicine (Hong 
Kong, China). Pooled human liver microsomes (HLMs) 
were supplied by GenTest Corporation (Woburn, MA, 
USA). 6-hydroxyflavone, trifluoroacetic acid (TFA, HPLC 
grade) and other chemicals were purchased from Sigma-
Aldrich Chemicals Co. (St. Louis, MO, USA).
Extraction procedures
In order to make an accurate/meaningful comparison, 
50  g of ground HQ was immersed in different solvents 
using various extraction methods. Heat reflux extraction 
using water (HRE-W) was performed according to the 
Chinese Pharmacopeia (Comission 2010) and HQ pow-
der was extracted (100  °C, 2 h). For microwave-assisted 
extraction using water (MAE-W), HQ powder was put 
into a 500-ml flask inside a MAS-II microwave oven 
(Shanghai SINEO Microwave Co., China) with micro-
wave power of 300 W connected to a water-jacket con-
denser to alter the atmospheric pressure inside the flask 
if necessary and heated at 100 °C for 2 h. For ultrasonic 
extraction (UE) using water (UE-W) or ethanol (UE-
E), HQ powder was extracted (1 h) at 45  °C with either 
water or ethanol (70  % vol/vol) with the same ultra-
sonic frequency (40  kHz) and power (250  W) (Branson 
8510 ultrasonicator, Branson, USA). All herbal mixtures 
obtained using different extraction methods were centri-
fuged at 5000g for 20 min before the supernatant of each 
sample was carefully collected. Supernatant obtained 
from the UE-E method was condensed under reduced 
pressure to remove ethanol. All extracts collected were 
then freeze-dried (Scanlaf Coolsafe 110-4 Freeze-dryer, 
LaboGene, Denmark) and weighed for extraction yield 
calculation before they were ground into powder. All 
ground powders were stored at −80  °C in a light-proof 
container before use. Three independent extractions were 
performed, and these three different batches of samples 
were individually evaluated in the following assays.
Identification and quantification of chemical profiles
Chemical analysis was carried out using an Agilent 
1100  LC/MSD  Trap (Agilent, Germany) equipped with 
a binary pump, an online degasser, an auto-sampler, a 
Diode Array Detector (DAD) and an APCI source using 
positive and negative ionization modes. Chromatography 
was performed at 30 °C with a Grace Alltima C18 column 
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(250 mm × 4.6 mm, 5 μm) protected by a C18 guard col-
umn (10 mm × 4.6 mm, 5 μm). The mobile phase consti-
tuted (A) 0.05 % TFA water (vol/vol) and (B) acetonitrile 
in a gradient elution: 20  % B at 0–10  min, 20–55  % B 
at 15–45  min, 55–80  % B at 45–50  min, and 80  % B at 
50–55  min (Horvath et  al. 2005). Injection volume was 
50  μl, and flow rate was set at 0.7  ml/min with detec-
tion wavelength at 280  nm and reference wavelength 
at 580  nm. The interface and mass spectrum detector 
(MSD) parameters employed were as follows: nebulizer 
pressure, 50 psi; dry gas, 5.0  l/min; dry gas tempera-
ture, 350  °C; vaporizer temperature: 400  °C; scan range 
100–1100 m/z; target mass, 500 m/z; compound stability, 
100 %. Stock solutions (10 mg/ml) of all authentic stand-
ards were prepared in methanol of analytical grade, and 
stored at 4  °C before use. Samples of HQ extracts were 
freshly prepared in water (10  mg/ml). Authentic stand-
ards and extract samples were diluted (methanol–water, 
50:50, vol/vol) to the desired concentrations. 6-hydroxy-
flavone was used as the internal standard (I.S.), and 
10 μl of I.S. (50 μg/ml) was used with 50 μl of individual 
sample. The quantitative method used in this study was 
validated based on the detection of baicalin, baicalein, 
wogonoside and wogonin.
Evaluation of antioxidant properties
The free radicals scavenging capacities (SC) were meas-
ured and compared using the DPPH assay (Chan et  al. 
2010). Briefly, 5  µl of individual extract (0.625–10  mg/
ml) was mixed with 195  μl of DPPH solution (24  mg/l) 
in a 96-well plate. The reaction was allowed to proceed in 
the dark for 30 min before the absorbance of the result-
ant solution was measured at 515 nm using a Micro-plate 
Absorbance Reader (Bio-Rad, CA, USA). Ascorbic acid 
(Sigma-Aldrich Chemicals Co., MO, USA) in distilled 
water served as the positive control. SC50 was estimated 
as the concentration of sample which scavenges 50 % of 
free radicals.
The FRAP assay was performed in a 96-well plate as 
described (Firuzi et al. 2005). Briefly, 5 µl of each sample 
was mixed with 150 µl of freshly prepared FRAP reagent 
(250  mM acetate buffer, pH 3.6; 8.3  mM 2,4,6-tripyri-
dyl-s-triazine dissolved in 40  mM HCl and 16.7  mM 
FeCl3·6H2O solution). After incubation at 37  °C for 
30 min, the absorbance of the solution was measured at 
593 nm. Different concentrations of Fe2+ standard solu-
tion were used for the construction of the standard curve, 
and ascorbic acid was used as the positive control.
Comparison of the protective effects of HQ extracts 
on hydrogen peroxide‑induced cell death
The protective effects of HQ extracts on hydrogen per-
oxide (H2O2)-induced cell death were evaluated using rat 
heart H9c2 cells (Chan et al. 2010). H9c2 cells were cul-
tured in high glucose DMEM with 10 % FBS, 100 units/
ml penicillin and 100 μg/ml streptomycin, and seeded 
into a 96-well plate at a density of 1.5 × 104 cells per well 
overnight before they were treated with HQ extracts 
(62.5–500 μg/ml, diluted from 50 mg/ml stock in DMSO) 
for 24  h. After treatment, the cells were washed twice 
with warmed PBS, and then 500 μM H2O2 diluted in 
DMEM was added and incubated for 6 h, followed by the 
addition of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT, 0.5  mg/ml in medium) 
for 3  h. Crystals formed were dissolved in DMSO and 
the absorbance of the solution was measured at 570 nm. 
The DMSO (1 %)-treated (without H2O2 or HQ extracts) 
group served as solvent control, whereas the H2O2-
treated (plus 1 % DMSO) group was the positive model 
for determination of cell death. The protective effects of 
HQ extracts against H2O2-induced cell death were esti-
mated and compared based on the calculated EC50 values 
of different HQ extracts.
Inhibition study on CYP450 isoforms
The inhibitory effects of HQ extracts on the activities 
of human CYP1A2, CYP2C9, CYP2D6 and CYP3A4 
in pooled human liver microsomes (HLMs) were stud-
ied using enzymatic reactions with probe substrates 
(50 μM) as follows: CYP1A2, phenacetin O-deethylation; 
CYP2C9, tolbutamide 4-hydroxylation; CYP2D6, dex-
tromethorphan O-demethylation; CYP3A4, testoster-
one 6β-hydroxylation. Incubation, samples preparation 
and subsequent HPLC analysis were carried out as pre-
viously described (Wang et al. 2010; Zhou et al. 2012b). 
Series of concentration of HQ extracts (1–1000  μg/ml) 
were prepared and the estimated inhibitory potency 
was expressed as IC50 value. To estimate the potential 
in vivo CYP enzymes inhibition caused by HQ extracts, 
the volume per dose index (VDI, liter per dose unit) was 
employed and VDI was calculated as the clinical dose 
unit of HQ extract divided by IC50 value, as reported 
(Strandell et al. 2004).
Statistical analysis
Data were statistically analyzed with one-way ANOVA 
followed by Bunnett’s Post Hoc using Prism v4.0 
(GraphPad Inc., CA) and the results were presented as 
mean ± SEM. P value <0.05 was considered statistically 
significant.
Results and discussion
Based on the dry weights i.e. the yields of the HQ crude 
extracts obtained (Table 1), MAE-W was the most effec-
tive extraction method (crude extract: 390.8 ± 16.6 mg/g) 
whereas HRE-W was less effective (crude extract: 
Page 4 of 10Zhou et al. SpringerPlus  (2016) 5:1438 
297.4  ±  28.4  mg/g) (i.e. MAE-E versus HRE-W: ~30  % 
increase). Using the UE method (a widely-used efficient 
method in a previous quality-control study on HQ) (Li 
et al. 2009), 327.4 ± 19.4 mg/g of HQ crude extract was 
obtained when ethanol (70  % vol/vol) was used as sol-
vent, whereas only 275.0 ± 9.0 mg/g of crude extract was 
obtained when water was used. Our results clearly illus-
trate that among all the extraction methods employed 
in this study, MAE-W was the most efficient method for 
herbal extraction based on the yield of HQ crude extract.
Figure  1 illustrates the HPLC–UV (at 280  nm) of 
base peak chromatographic (BPC) profiles of authentic 
standards used. Nine major HPLC peaks were detected 
and identified as flavones in the HPLC chromatogram. 
Compounds 3, 6, 7 and 8 were identified as baicalin, 
wogonoside, baicalein and wogonin, respectively. Other 
components were identified using APCI-MS methods 
(Table  2). The glycoside (e.g. baicalin) exhibited a sig-
nificant MS signal in both positive and negative modes, 
whereas aglycone (e.g. baicalein) was observed only in 
positive mode. In the MS spectra, all analyzed com-
pounds exhibited a noticeable protonated [M + H]+ ion 
in positive mode. However, in negative mode, no consist-
ent pattern was detected. The O-linked glycosides such 
as baicalin and wogonoside exhibited an intensive adduct 
ion [M + TFA]− which produced a [M − H]− ion in MS2. 
The multi-stage MS of [M + H]+ or [M − H]− of O-linked 
glycosides provided information about the loss of sugar 
moiety, and the structure of aglycones was formed. Com-
pounds 4 and 5 were O-linked glycosides, and they were 
identified as norwogonin-7-O-glucuronide (norwogonin-
7-O-GlcA) and chrysin-7-O-glucuronide (chrysin-7-
O-GlcA) respectively as previously reported (Han et  al. 
2007; Liu et  al. 2009). On the other hand, Compounds 
1 and 2 demonstrated a dominant pseudo-molecular 
ion [M  −  H]− in their respective MS spectra, illustrat-
ing the existence of [M − H − 60]−, [M − H − 90]− and 
[M  −  H  −  120]− ions, which are the characteristics of 
typical C-linked glycosides (Han et  al. 2007; Liu et  al. 
2009). Moreover, the MSn data suggested that Com-
pound 1 was chrysin-6-C-arabinosyl-8-C-glucoside 
(chrysin-6-C-Ara-8-C-Glc) and Compound 2 was chry-
sin-6-C-glucosyl-8-C-arabinoside (chrysin-6-C-Glc-
8-C-Ara). Compound 9 was an isomer of Compound 8 
(wogonin) and it was probably oroxylin A according to 
the retention time and MS fragments.
The chemical profiles and quantity of four marker 
compounds in HQ extracts obtained are shown in 
Fig.  2a. Our results demonstrated that MAE-W (baica-
lin, 190.1  ±  4.4  μg/mg; wogonoside, 37.7  ±  1.7  μg/mg; 
baicalein, 21.8 ±  2.1 μg/mg; wogonin, 7.1 ±  0.2 μg/mg) 
and HRE-W (baicalin, 186.0  ±  6.4  μg/mg; wogonoside, 
37.8 ± 1.5 μg/mg; baicalein, 22.0 ± 1.8 μg/mg; wogonin, 
7.3 ± 0.1 μg/mg) methods gave similar results in terms of 
the quantity of these compounds. In addition, these two 
extraction methods did not affected the chemical profiles 
of the HQ extracts obtained with a constant ratio of 5:1 
for baicalin/wogonoside. On the other hand, HQ extract 
contained less baicalin (163.0 ± 6.3 μg/mg) but more bai-
calein (48.2 ±  7.6  μg/mg) and wogonin (15.6 ±  1.5  μg/
mg) when UE-E was used. These results are consistent 
with the observations of some previous studies on HQ 
extraction using organic solvent (Horvath et al. 2005; Lin 
et al. 1996). However, when water was used as solvent in 
the UE procedures, HQ extract obtained had the least 
amount of baicalin (0.8  ±  0.3  μg/mg) and wogonoside 
(0.8 ± 0.3 μg/mg) among all extraction methods used in 
this study.
Besides, there were no significant differences in the 
amount of water-soluble components (e.g. chrysin-6-C-
Ara-8-C-Glc, chrysin-6-C-Glc-8-C-Ara, norwogonin-7- 
O-GlcA and chrysin-7-O-GlcA) and lipid components 
(like oroxylin A) present in the extracts prepared by 
MAE-W and HRE-W (Fig.  2b). As expected, using UE 
with ethanol, the yield of most water-soluble components 
were lower compared with those prepared by MAE-W 
and HRE-W (e.g. 19  % decrease of baicalin), whereas 
higher yields of the major lipid-soluble components (e.g. 
baicalein, 119 %; wogonin, 79 %; oroxylin A, 197 %) were 
observed probably due to the higher solubility of these 
compounds in ethanol. When water was used as solvent 
in UE, the least amount of these identified compounds 
Table 1 Summary of the yields of crude extracts (dry weight, mg) obtained from ground Huang-Qin (50 g) using different 
extraction methods
Results are expressed as mean ± SEM (n = 3)
*** P < 0.001 compared to HRE-W
Extraction methods Abbreviation Crude extract (mg/g herb)
Heat reflux extraction using water HRE‑W 297.4 ± 28.4
Microwave‑assisted extraction using water MAE‑W 390.8 ± 16.6***
Ultrasonic extraction using ethanol (70 % vol/vol) UE‑E 327.4 ± 19.4
Ultrasonic extraction using water UE‑W 275.0 ± 9.0
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could be obtained. These results therefore suggested 
that based on the profiles and quantity of all chemicals 
detected in the extracts, the MAE-W method is as good 
as the commonly used HRW-E method, whereas the 
efficiency and effectiveness of the UE method is highly 
dependent on the solvent used.
Baicalein, wogonin and their glycosides contribute 
significantly to the total weight of HQ (Su et  al. 2008), 
Peak 
No. 
RCompounds 1 R2 R3 R4
1 Chrysin-6-C-arabinosyl-8-C-glucoside OH Ara OH Glc 
2 Chrysin-6-C-glucosyl-8-C-arabinoside OH Glc OH Ara 
HAclGOHOHOBaicalin3
4 Norwogonin-7-O-glucuronide OH H OGlcA OH 
5 Chrysin-7-O-glucuronide OH H OGlcA H 
HCOAclGOHHOedisonogoW6 3
HHOHOHOBaicalein7
HCOHOHHOWogonin8 3
HCOHOOroxylin A9 3 OH H 
I.S. 6-hydroxyflavone H OH H H 
Ara = ; Glc = ; GlcA = . 
Fig. 1 Representative HPLC–UV (at 280 nm) of base peak chromatographic profiles of authentic standards used. Nine major HPLC peaks were 
detected and identified as flavones. Their chemical structures are also shown. 6‑hydroxyflavone was used as the internal standard (I.S.)
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and these flavones are strong antioxidants. It is there-
fore feasible to utilize both the chemical profiles and the 
antioxidant properties of HQ extract for quality control 
purposes for all HQ-containing products in the mar-
ket (Boyle et al. 2011). Table 3 illustrates that there were 
no significant differences in the free radicals scaveng-
ing activities (as estimated by DPPH assay) of extracts 
prepared by the extraction methods (SC50: MAE-W, 
1.046  ±  0.064  mg/ml; HRE-W, 0.958  ±  0.032  mg/ml; 
UE-E, 0.988 ± 0.057 mg/ml). However, extract prepared 
by the UE-W method has the weakest scavenging activ-
ity (SC50: 3.899  ±  0.175  mg/ml), whereas ascorbic acid 
is the strongest scavenger (SC50: 0.107 ±  0.004  mg/ml). 
The results obtained from the FRAP assay demonstrated 
a similar trend of antioxidant properties of HQ extracts 
prepared by different extraction methods (Table 3).
Due to the relatively low yield (the lowest yield among 
all extraction methods) of bioactive components and 
antioxidant activity of the extract obtained, water extract 
of HQ obtained from UE was therefore not evaluated. As 
illustrated in Table  4, all HQ extracts (HRWE, MAE-W 
and UE-E) demonstrated a similar protective effect (EC50 
of 176.4  ±  14.5, 190.6  ±  12.1 and 165.7  ±  19.9  μg/ml, 
respectively) against H2O2-induced cell death as deter-
mined by MTT assay. Interestingly, these cell-based 
results were comparable to the results of antioxidant/
free radicals scavenging assays as discussed in previous 
sections.
There is little information in the literature that com-
pares the hepatic enzymes inhibitory effects of HQ 
extracts prepared by different methods. Some HQ fla-
vones, which are abundant especially when using etha-
nol as solvent for extraction, demonstrated substantial 
inhibition of human hepatic drug metabolizing enzymes 
cytochrome P450s (CYP 450s) such as CYP2C9 (Si et al. 
2009), CYP3A4, CYP1A2 (Kim et al. 2002; Li et al. 2011) 
and CYP2D6 (Mo et al. 2012). Therefore, it is important 
to evaluate whether the extract obtained using MAE-W 
method has different inhibitory profiles compared with 
other extraction methods on hepatic CYP450 enzymes. 
HQ extract obtained by the HRE-W method was used as 
reference for comparison.
Extracts obtained by MAE-W demonstrated a moder-
ate inhibition of CYP1A2 and CYP2C9 (as indicated by 
9 and 20 % decrease in IC50 values, respectively) whereas 
an “enhancement” rather than an inhibition (i.e. ~ 40 % 
Table 2 Characterization of major ingredients in Huang-Qin extract by HPLC–DAD–APCI–MS
a The peak number is the same as indicated in Fig. 1
b Identities of compounds were established by comparison with the authentic compounds
c On-line identification by HPLC–MSn analysis
Peak no.a tR (min) UV
λmax
MSn (m/z) and relative abundance (% base peak) Identification
1 14.0 215, 275, 318 APCI+—MS: 549(100); MS2 [549]: 531(70), 513(60), 495(90), 483(20), 465(45), 
429(10), 411(100), 393(30), 363(10); MS3 [411]: 393(100), 375(60), 363(70), 
333(80), 309(30), 279(28)
APCI−—MS: 547(100); MS2 [547]: 529(20), 511(10), 487(85), 457(100), 427(42), 
409(10), 367(60), 337(70); MS3 [457]: 367(10), 337(100)
Chrysin‑6‑C‑arabinosyl‑8‑C‑
glucosidec
2 17.6 215, 275, 318 APCI+—MS: 549(100); MS2 [549]: 531(100), 513(30), 495(20), 483(45), 465(20), 
453(18), 441(18), 411(10), 393(8), 381(6); MS3 [531]: 513(80), 495(60), 
483(100), 465(75), 453(70), 441(60), 411(12), 393(30), 381(50), 363(40)
APCI−—MS: 547(100); MS2 [547]: 529(15), 487(15), 457(70), 427(100), 367(20), 
337(30); MS3 [427]: 367(15), 337(100)
Chrysin‑6‑C‑glucosyl‑8‑C‑
arabinosidec
3 27.3 215, 277, 316 APCI+—MS: 447(100), 271(20); MS2 [447]: 271(100); MS3 [271]: 253(40), 
241(100)
APCI−—MS: 559(100); MS2 [559]: 445(100); MS3 [445]: 269(100)
Baicalinb
4 29.7 215, 280, 360 APCI+—MS: 447(100), 271(20); MS2 [447]: 271(100)
APCI−—MS: 559(20), 445(100); MS2 [559]: 445(100); MS3 [445]: 269(100)
Norwogonin‑7‑O‑glucu‑
ronidec
5 30.8 215, 273, 312 APCI+ – MS: 431(100), 255(20); MS2 [431]: 255(100)
APCI−—MS: 543(100); MS2 [543]: 429(100); MS3 [429]: 253(100), 173(40)
Chrysin‑7‑O‑glucuronidec
6 32.3 215, 275, 349 APCI+—MS: 461(100); MS2 [461]: 285(100); MS3 [285]: 270(100)
APCI−—MS: 573(100); MS2 [573]: 459(100); MS3 [459]: 283(100), 268(20), 
174(30)
Wogonosideb
7 40.1 215, 275, 322 APCI+—MS: 271(100); MS2 [271]: 241(100) Baicaleinb
8 48.0 210, 275 APCI+—MS: 285(100); MS2 [285]: 270(100) Wogoninb
9 50.5 215, 273, 318 APCI+—MS: 285(100); MS2 [285]: 270(100) Oroxylin Ac
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increase in IC50 value) of CYP3A4 activity was observed 
(Table  5). There was a similar magnitude of CYP2D6 
inhibition caused by HQ extracts obtained by MAE-W 
and HRE-W. On the other hand, extract obtained by 
UE-E had a marked inhibition on CYP1A2, CYP2C9 and 
CYP2D6 (as illustrated by 63 to 71 % decrease in IC50 val-
ues) and only a weak inhibition (~39 % decrease in IC50) 
of CYP3A4 was observed. Previous studies reported that 
HQ extract caused CYP450s inhibition mainly through 
the flavones and flavones glycosides present in the extract 
(Kim et al. 2002; Li et al. 2011). However, CYP1A2 inhi-
bition by flavone glycosides of HQ extracts has not been 
reported.
Volume per dose index (VDI) has been employed for 
the estimation of possible in  vivo herb–drug interac-
tions in in  vitro incubation using human pooled liver 
Fig. 2 Effects of extraction methods on a the contents of marker compounds and b the estimated contents of other identified ingredients in 
Huang‑Qin extracts. Results are expressed as mean ± SEM (n = 3). **P < 0.01 and ***P < 0.001 compared to HRE‑W
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microsomes. As proposed by Strandell et al. (2004), when 
VDI is greater than 4  l (i.e. human blood volume), it is 
likely that in vivo herb–drug interactions occurred with 
the participation of hepatic CYP enzymes. According to 
the National Drug Standards (Traditional Chinese Medi-
cine Prescription, Volume 2) (Ministry of Health, PR of 
China), the dose unit of HQ tablets is about 650 mg HQ 
extract in which 117  mg is baicalin. Based on this dose 
unit and the respective IC50 values, the VDI of individ-
ual CYP450 isoforms were estimated (Table 5). The esti-
mated VDIs of all HQ extracts examined on CYP1A2, 
CYP2C9 and CYP2D6 enzymes were greater than 4  l 
per dose unit. More importantly, based on the estimated 
VDIs, only the extract obtained using UE-E method illus-
trated a significant in  vivo herb–drug interaction with 
CYP3A4-metabolized Western drugs. Taken together, 
our results clearly demonstrated that HQ extracts, irre-
spective of the extraction methods/solvents used, possess 
significant herb–drug interactions with CYPs-metabo-
lized Western medicines.
Recent pharmacological and toxicological studies indi-
cated that water-soluble components of HQ extract exhibit 
a variety of therapeutically useful activities with relatively 
low toxicity (Yimam et  al. 2010), whereas long-term tox-
icity (e.g. damage to the bile duct) of extracts prepared 
using organic solvent has been reported (Ong et al. 2004) 
although herbal extraction using organic solvent (e.g. UE-E 
in this study which possesses a significant herb–drug inter-
action with CYP3A4-metabolized drugs) is not a com-
mon practice for human consumption. Taken together, 
our results illustrate that MAE-W provided an effective 
and efficient procedure in terms of a higher yield of crude 
extract collected than the conventional HRE-W, and more 
importantly HQ extract prepared by this procedure has 
similar pharmacological activities with a lesser magnitude 
of herb–drug interactions when compared with extracts 
prepared using other organic-solvent extraction methods. 
It remains to be determined whether this favorable cost-
efficient extraction method could be used in preparation of 
extracts of more expensive Chinese herb such as Cordyceps 
for therapeutic uses without affecting their pharmacologi-
cal effects.
Table 3 Summary of  the antioxidant potential of  Huang-
Qin extracts prepared by  different extraction methods 
as estimated by DPPH assay (SC50, mg/ml) and FRAP assay 
(μmol Fe2+/mg extract)
Results are expressed as mean ± SEM (n = 3)
*** P < 0.001 compared to HRE-W
a 1 mM was used
Samples DPPH assay  
(SC50, mg/ml)
FRAP assay  
(μmol Fe2+/mg extract)
Ascorbic acida 0.107 ± 0.004*** 2278 ± 15***
HRE‑W 0.958 ± 0.032 1249 ± 131
MAE‑W 1.046 ± 0.064 1306 ± 71
UE‑E 0.988 ± 0.057 1359 ± 29
UE‑W 3.899 ± 0.175*** 541.6 ± 98***
Table 4 Summary of  the protective effects [expressed 
as EC50 (μg/ml)] of Huang-Qin extracts prepared by differ-
ent extraction methods against  H2O2-induced cell death 
(estimated by MTT assay) using rat heart H9c2 cells
Results are expressed as mean ± SEM (n = 3)
Samples EC50 (μg/ml)
HRE‑W 176.4 ± 14.5
MAE‑W 190.6 ± 12.1
UE‑E 165.7 ± 19.9
Table 5 Summary of  the inhibitory effects [expressed as  IC50 (μg/ml) and  volume per  dose index (VDI, L/dose unit)] 
of Huang-Qin (HQ) extracts prepared by different extraction methods on model probes’ metabolism
Results are expressed as mean ± SEM (n = 3)
* P < 0.05; ** P < 0.01 and *** P < 0.001 compared to HRE-W
a Furafylline for CYP1A2; Sulfaphenazole for CYP2C9; Quinidine for CYP2D6; Ketoconazole for CYP3A4. Results of the positive controls included in this Table for 
comparison have been published in our previous work (Wang et al. 2010; Zhou et al. 2012b)
Samples CYP1A2 CYP2C9 CYP2D6 CYP3A4
IC50 VDI IC50 VDI IC50 VDI IC50 VDI
HRE‑W 8.13 ± 0.08 80.0 38.87 ± 0.60 16.7 131.3 ± 5.35 4.95 174.1 ± 4.86 3.74
MAE‑W 7.42 ± 0.20* 87.6 30.71 ± 0.84*** 21.2 135.3 ± 6.43 4.80 243.0 ± 11.81** 2.68
UE‑E 3.00 ± 0.12*** 216.7 11.25 ± 0.66*** 57.8 38.29 ± 1.28*** 17.0 106.6 ± 4.53** 6.10
Positive controlsa 0.640 – 0.138 – 0.292 – 0.047 –
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